Autologous CAR-T Cell Manufacturing: Current Standing and Future Directions
A Look at What Drug Manufacturers are Likely Using to Make CAR-T Products
Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
For full access to this article login to GEN Select now.
CMOs Seek "the" Competitive Edge
Established Practices Like Lyophilization and Six Sigma Are Finding Novel Uses in Biotech
- Contract manufacturers are embracing new uses of established techniques to give them an edge in an increasingly competitive environment, according to companies exhibiting at the “Interphex” conference later this month in New York City. Examples of such practices include lyophilization, single-use manufacturing, and established decision frameworks like Six Sigma. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.